{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T11:21:20Z","timestamp":1787829680078,"version":"build-2784847793"},"reference-count":29,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Emerg Medicine Australasia"],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Nephrotoxicity has been reported with prolonged use of aminoglycosides but is considered low\u2010risk with single\u2010dose empirical therapy. However, limited data exist in patients with chronic kidney disease (CKD). The aim of this study was to determine the safety of single\u2010dose aminoglycosides (SDA) in Emergency Departments (ED) in patients with and without CKD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective cohort study was performed in four tertiary hospitals within a multi\u2010site Australian metropolitan hospital network. Electronic medical records of all adult patients who presented to ED and received SDA between August 2019\u2013July 2024 were screened for inclusion. The primary outcome was AKI incidence within 1\u2009week of SDA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Overall, 6636 aminoglycoside administrations were identified, 1835 screened and 660 patients were included. Patients received gentamicin (74.1%), tobramycin (25.6%), or amikacin (0.3%). Patients with CKD were older (81.3 vs. 64.1\u2009years,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001) and had more comorbidities. AKI incidence within 1\u2009week of hospitalisation was higher in patients with vs. without CKD (30.9% vs. 13.4%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). Patients with CKD had more severe AKI (stage 2: 10.1% vs. 2.6%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001) and had numerically, but not statistically, higher mortality and intensive care unit admission rates compared to patients without CKD. CKD was associated with a higher likelihood of AKI incidence (OR 2.88 [95% CI: 1.76\u20134.71],\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Patients with CKD who received single\u2010dose aminoglycosides were more likely to have AKI compared to patients without CKD. Clinicians should carefully balance the risks and benefits of empiric aminoglycosides in patients with CKD and consider such therapy only if no other suitable alternatives exist.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/1742-6723.70318","type":"journal-article","created":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T01:00:30Z","timestamp":1785546030000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Safety of Single Aminoglycoside Dose in Emergency Departments (\n                    <scp>SAD<\/scp>\n                    \u2010\n                    <scp>ED<\/scp>\n                    ) Among Patients With and Without Chronic Kidney Disease: A Retrospective Cohort Study"],"prefix":"10.1111","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5497-938X","authenticated-orcid":false,"given":"Grace","family":"Lau","sequence":"first","affiliation":[{"name":"Pharmacy Department Monash Health  Melbourne Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Xin","sequence":"additional","affiliation":[{"name":"Pharmacy Department Monash Health  Melbourne Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3178-5388","authenticated-orcid":false,"given":"Roy","family":"Kadira","sequence":"additional","affiliation":[{"name":"Pharmacy Department Monash Health  Melbourne Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia","family":"Andrew","sequence":"additional","affiliation":[{"name":"Pharmacy Department Monash Health  Melbourne Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7375-073X","authenticated-orcid":false,"given":"Iouri","family":"Banakh","sequence":"additional","affiliation":[{"name":"Pharmacy Department Monash Health  Melbourne Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,7,31]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02165\u201018"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2010.337"},{"key":"e_1_2_9_4_1","volume-title":"Therapeutic Guidelines","author":"Antibiotic","year":"2025"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciae403"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.18773\/austprescr.2025.038"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2023.08.031"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.11290821"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.13439"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0236864"},{"issue":"3","key":"e_1_2_9_11_1","first-page":"2021","article-title":"Acute Kidney Injury and Single\u2010Dose Administration of Aminoglycoside in the Emergency Department: A Comparison Through Propensity Score Matching","volume":"38","author":"Venturini S.","year":"2021","journal-title":"Giornale Italiano di Nefrologia"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1186\/cc6863"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcp143"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.3109\/23744235.2015.1109136"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix186"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2014010035"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfs458"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2014.05.090"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.12968\/jokc.2018.3.4.218"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajag.12541"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2014.328"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2023.10.018"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/kisup.2012.1"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.0000000000000044"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2020.06.030"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2022.12.008"},{"key":"e_1_2_9_27_1","volume-title":"Acute Kidney Injury in Australia: A First National Snapshot","author":"Thao V.","year":"2015"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.xkme.2019.06.005"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2013.153"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1002\/phar.1918"}],"container-title":["Emergency Medicine Australasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/1742-6723.70318","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/1742-6723.70318","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/1742-6723.70318","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T10:48:26Z","timestamp":1787827706000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/1742-6723.70318"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,31]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["10.1111\/1742-6723.70318"],"URL":"https:\/\/doi.org\/10.1111\/1742-6723.70318","archive":["Portico"],"relation":{},"ISSN":["1742-6731","1742-6723"],"issn-type":[{"value":"1742-6731","type":"print"},{"value":"1742-6723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,31]]},"assertion":[{"value":"2025-12-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-20","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-31","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70318"}}